Tardive Dyskinesia (TD) | AUSTEDO XR® (deutetrabenazine) …
AUSTEDO XR ® (deutetrabenazine) extended-release tablets and AUSTEDO ® (deutetrabenazine) tablets are indicated in adults for the treatment of chorea associated with Huntington’s disease and …
AUSTEDO XR® Medication for Tardive Dyskinesia (TD)
Once-daily AUSTEDO XR® (deutetrabenazine) extended release tablets reduce uncontrollable Tardive Dyskinesia (TD) body movements. See safety info including Boxed Warning.
Austedo (deutetrabenazine): Uses, Side Effects, Dosage Guide
Aug 20, 2025 · Austedo's drug class is a VMAT2 inhibitor (vesicular monoamine transporter 2 inhibitor). Austedo tablets are taken twice daily, and the Austedo XR (extended-release) tablets are taken once …
Patients Taking AUSTEDO XR® (deutetrabenazine) - GlobeNewswire
Sep 21, 2025 · The most common adverse reactions for AUSTEDO (4% and greater than placebo) in controlled clinical studies in patients with tardive dyskinesia were nasopharyngitis and insomnia.
Austedo for Uncontrolled Movements in Huntington’s and Tardive Dyskinesia
Jul 16, 2024 · Austedo (aw-STED-oh) was approved in 2017 and is the first medicine approved to treat both tardive dyskinesia and chorea caused by Huntington’s disease.
FDA Approves One Pill, Once-Daily Tablets of Deutetrabenazine for ...
May 30, 2024 · Key Takeaways Deutetrabenazine (Austedo XR) is now available as a once-daily, extended-release tablet for tardive dyskinesia and Huntington disease chorea, enhancing dosing …
Austedo XR Approved: A New Treatment Option for Tardive Dyskinesia …
May 30, 2024 · The FDA has approved Austedo XR as a once-daily pill treatment option for tardive dyskinesia and Huntington disease chorea control.
Teva Announces FDA Approval of AUSTEDO® XR ... - Teva …
Feb 17, 2023 · The most common adverse reactions for AUSTEDO (4% and greater than placebo) in controlled clinical studies in patients with tardive dyskinesia were nasopharyngitis and insomnia. …
Study Explores Tardive Dyskinesia Outcomes With Deutetrabenazine …
Nov 12, 2024 · It demonstrates real-world treatment patterns and outcomes with once-daily Austedo XR (deutetrabenazine) extended-release tablets and twice-daily Austedo (deutetrabenazine) tablets, …
The dose of deutetrabenazine (Austedo) is determined individually for each patient based on reduction of chorea or tardive dyskinesia and tolerability. The package insert contains specific dosing …